Team

Background from banking and finance, business development, and as an investor. Has in recent years been involved in development, and financing for several start-ups in Norway and internationally. Co-founder of Balancial and has held position as CEO and part of the board in Balancial and its subsidiaries since 2020. Background: BSc, Economics & Administration, specializing in finance.

Daniel has broad experience from corporate finance, investments, business development and company building. In his role as Group Director – Strategy & Business Development, he works across the Balancial Group with strategy, investor relations, capital processes, strategic partnerships, commercial opportunities and the development of new markets. He has a particular focus on turning opportunities into scalable business, combining financial understanding with a commercial and strategic perspective. Daniel works closely with management across the Group on growth initiatives, partnerships and the continued development of Balancial in Germany, Denmark and other European markets. Daniel also serves as CEO of Balancial Denmark ApS and as a Board Member of Balancial AS. BSc, Economics & Administration, specializing in Business Development.

Christine was General Manager under Trade Law at Medizinalcannabis Vertriebs GmbH in Austria, where she played a key role in establishing the Quality Management System and obtaining GMP certification. With expertise in pharmaceutical quality management, cannabinoids, and regulatory affairs, she brings valuable knowledge to her role as COO at Balancial GmbH. She holds university degrees in Chemistry, and French.

Ørnulf daily lawyer with his own practice in Bergen. He has extensive experience from several listed companies in roles such as CEO and legal director. He also has experience in international business management and several board positions.

Trine has a broad business background from shipping, marketing, and sales, as well as strategy development and market analysis. Portfolio manager and investor through Teigland Eiendom AS and holds board positions in listed Lifecare.

Bjarte Askeland is a section chief physician in Orthopedic Anesthesia at Haukeland Hospital, and general manager of the Norwegian Anesthesiology Association. Askeland has a master's degree from the Faculty of Medicine, University of Bergen 1979-1985, and has worked as a specialist in anaesthesiology since 1996.

Nina holds the regulatory title «Competent Person» and is responsible for Balancial's QMS system. Nina has extensive experience in the pharmaceutical industry, including from Novo Nordisk in Denmark and later as a consultant and consultant. Education: MSc Pharmaceutical Sciences.

Maik Dobiey joined Balancial in March 2025 to lead sales. He brings deep experience in the German medical cannabis market, with an extensive network across pharmaceutical companies, wholesalers, and specialized pharmacies. Most recently, he served as head of pharmacy sales and delivered strong growth. Maik is fluent in German, English, and Spanish, and has international experience from working in over 16 countries. He brings a strategic mindset and hands-on approach to Balancial’s sourcing and sales efforts.